Nilsine Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $832K | Buy |
1,585
+239
| +18% | +$125K | 0.08% | 217 |
|
|
2025
Q1 | $854K | Buy |
1,346
+340
| +34% | +$216K | 0.09% | 199 |
|
|
2024
Q4 | $717K | Buy |
1,006
+27
| +3% | +$19.2K | 0.08% | 214 |
|
|
2024
Q3 | $1.03M | Sell |
979
-72
| -7% | -$75.7K | 0.13% | 173 |
|
|
2024
Q2 | $1.1M | Sell |
1,051
-131
| -11% | -$138K | 0.15% | 158 |
|
|
2024
Q1 | $1.14M | Buy |
1,182
+23
| +2% | +$22.1K | 0.16% | 156 |
|
|
2023
Q4 | $1.02M | Sell |
1,159
-258
| -18% | -$227K | 0.16% | 161 |
|
|
2023
Q3 | $1.17M | Buy |
1,417
+6
| +0.4% | +$4.94K | 0.18% | 142 |
|
|
2023
Q2 | $1.01M | Buy |
1,411
+8
| +0.6% | +$5.75K | 0.15% | 165 |
|
|
2023
Q1 | $1.15M | Buy |
+1,403
| New | +$1.15M | 0.18% | 149 |
|